Late-breaking Results Show Efficacy for CCM in Patients With HFpEF

Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people…

DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES PARTNERSHIP WITH AGA KHAN UNIVERSITY TO LAUNCH FIRST ALZHEIMER’S RESEARCH INITIATIVE IN EAST AFRICA

Partnership Addresses the Growing Alzheimer’s Epidemic in Africa GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) — Research Will Produce Digital Cognitive Assessments and Collect Blood Samples for Gene Sequencing Models Clinical Trial Will Conduct Late-Stage Potential Treatment for Alzheimer’s Builds on AKU’s Brain and Mind Institute to Develop Integrated Brain…

DAVOS ALZHEIMER’S COLLABORATIVE ANNOUNCES EARLY DETECTION INNOVATION GRANTS

$4.5 Million in Grant Funding Expands New Alzheimer’s Early Detection and Healthcare System Preparedness Efforts GENEVA, SWITZERLAND, May 23, 2022 (GLOBE NEWSWIRE) — The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s disease, today announced the recipients of a grant program aiming for early detection of cognitive symptoms. The early…

Crocus fournit la détection de courant isolée sans contact de l’avenir, avec une haute précision et pour des courants élevés

Le CT45x met en valeur les avantages des capteurs TMR pour repenser et simplifier les solutions dans l’espace des applications de haute précision à courant élevé MILPITAS, Californie, 23 mai 2022 (GLOBE NEWSWIRE) — Crocus Technology Inc., le premier fournisseur de capteurs XtremeSense® TMR (magnétorésistance à effet tunnel) ultramodernes, a…